共 185 条
[1]
Schotten U(2011)Pathophysiological mechanisms of atrial fibrillation: a translational appraisal Physiol Rev 91 265-325
[2]
Verheule S(2011)Recent advances in the molecular pathophysiology of atrial fibrillation J Clin Invest 121 2955-2968
[3]
Kirchhof P(2010)Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study Am Heart J 159 850-856
[4]
Goette A(2011)Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study) Am J Cardiol 108 227-232
[5]
Wakili R(2011)Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy: association with insulin resistance J Cardiol 58 18-25
[6]
Voigt N(2003)Inflammation as a risk factor for atrial fibrillation Circulation 108 3006-3010
[7]
Kääb S(2006)Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells Arterioscler Thromb Vasc Biol 26 611-617
[8]
Dobrev D(2010)Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro J Pharmacol Exp Ther 334 206-213
[9]
Nattel S(2013)Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice PLoS One 8 e76786-677
[10]
Chamberlain AM(2013)Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of Metformin in Phosphatase and Tensin Homolog-Deficient RAW264.7 Cells Immunopharm Immunot 35 669-455